10-Q: QT Imaging Holdings Reports Q1 2026 Financials

QT Imaging Holdings, Inc. reported a significant increase in revenue for the first quarter of 2026, driven by higher scanner sales, alongside continued investment in R&D and SG&A.

Summary

• QT Imaging Holdings, Inc. reported revenue of $6.5 million for the three months ended March 31, 2026, a substantial increase of 133% compared to $2.8 million in the same period of 2025.
• Gross profit increased by 47% to $2.7 million, while cost of revenue rose by 291% to $3.9 million.
• Operating expenses increased by 76% to $5.0 million, with Research and Development up 102% to $1.7 million and Selling, General, and Administrative expenses up 65% to $3.3 million.
• The company reported a net loss of $3.4 million for the quarter, an improvement from a net loss of $11.1 million in Q1 2025.
• As of March 31, 2026, the company had $6.9 million in cash and cash equivalents.
• The company extended the maturity date of its Lynrock Lake Term Loan to March 31, 2029, and increased the interest rate to 12%.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, with strong revenue growth offset by continued losses and significant ongoing capital needs. The Nasdaq uplisting and extended debt maturity are positive developments, but the geopolitical risks in the Middle East and the company's overall financial precariousness temper optimism.

Positives

• Revenue increased by 133% to $6.5 million in Q1 2026 compared to Q1 2025, driven by the sale of 13 Breast Acoustic CT Scanners.
• Gross profit increased by 47% to $2.7 million.
• Net loss improved significantly to $3.4 million in Q1 2026 from $11.1 million in Q1 2025.
• The company successfully uplisted its common stock to the Nasdaq Capital Market on January 28, 2026.
• The maturity date of the Lynrock Lake Term Loan was extended to March 31, 2029, providing extended financial runway.
• Distribution agreements with NXC Imaging, Gulf Medical Co., and Al Naghi Medical Co. provide significant Minimum Order Quantities (MOQs) for future revenue.

Negatives

• Cost of revenue increased significantly by 291% to $3.9 million.
• Operating expenses increased by 76% to $5.0 million, with R&D and SG&A expenses rising substantially.
• The company continues to incur net operating losses and negative cash flows from operations.
• As of March 31, 2026, the company had an accumulated deficit of $56.4 million.
• The company faces ongoing liquidity concerns and the need to raise additional capital.
• The company is unable to ship scanners to distributors in the Middle East due to ongoing armed conflicts, which could materially impact its business.

Risks

• The company has a history of net losses and negative cash flow from operations and expects these to continue.
• There is no assurance that the company will achieve profitability or sustain it.
• Future sales of common stock could dilute existing stockholders and depress the stock price.
• The company's ability to raise additional capital on acceptable terms is uncertain.
• Geopolitical tensions in the Middle East could disrupt product shipments and impact global markets.
• The company's reliance on a few key customers for a significant portion of its accounts receivable and revenue presents a concentration risk.

Future Outlook

The company believes that cash on hand, proceeds from recent PIPE transactions, and expected revenue from distribution agreements will be sufficient to fund its operating plan for at least the next 12 months. However, future capital requirements are significant, and the company may need to raise additional capital through equity or debt financing, which could result in dilution or restrictive covenants. The company expects to continue incurring losses and may never achieve profitability.

Management Comments

• We believe that the additional cash received from the Lynrock Lake Term Loan, the extension of the maturity date of the Lynrock Lake Term Loan to March 2029, the additional cash received from the PIPE Investments, and the expected revenue from MOQs per the Amended NXC Distribution Agreement, the Gulf Medical Distribution Agreement, and the Al Naghi Distribution Agreement will be sufficient to fund our current operating plan for at least the next 12 months.
• We expect to continue to incur losses, and our ability to achieve and sustain profitability will depend on the achievement of sufficient revenue to support our cost structure. We may never achieve profitability and, unless and until we do, we will need to continue to raise additional capital.

Industry Context

StockSavvy.ai notes that QT Imaging Holdings operates in the competitive medical device industry, focusing on innovative imaging systems. The company's strategy relies on technological advancement, strategic partnerships, and expanding market access, which are common themes in this sector. The recent uplisting to Nasdaq is a positive step for visibility and potential future fundraising.

Comparison to Industry Standards

• The revenue growth of 133% in Q1 2026 is strong, but the company is still in a pre-profitability stage, which is common for many medical device startups.
• Operating expenses, particularly R&D and SG&A, are increasing significantly, reflecting ongoing investment in product development and market expansion, a typical characteristic of companies in this phase.
• The company's reliance on debt financing and equity raises, along with its accumulated deficit, highlights the capital-intensive nature of medical device development and commercialization, similar to many peers in the sector.

Legal Proceedings

• Management is not aware of any pending claims that will have a material impact on the unaudited condensed consolidated financial statements.

Related Party Transactions

• The company entered into a Securities Purchase Agreement on April 24, 2025, for approximately $0.5 million from related persons (Dr. Avi Katz and Dr. Raluca Dinu).
• The company entered into a Securities Purchase Agreement on January 22, 2026, for approximately $0.2 million from a related party (Dr. Avi Katz).
• Outstanding convertible notes to three stockholders total $3.9 million, with accrued interest of $0.8 million as of March 31, 2026.
• A working capital note to a stockholder is outstanding for $0.7 million, interest-free, maturing October 1, 2027.
• A sublease agreement with a related party generates $6 thousand per month in rental fees through May 31, 2027.

Stakeholder Impact

• Shareholders: Potential dilution from future equity raises, but also potential upside from revenue growth and Nasdaq listing.
• Creditors: The extension of the Lynrock Lake Term Loan maturity to 2029 provides some comfort, but the company's ability to repay remains a concern.
• Suppliers: Increased inventory purchases may benefit suppliers, but the company's financial health could impact payment reliability.
• Employees: Continued investment in R&D and SG&A suggests ongoing employment opportunities, but the company's financial situation poses job security risks.

Next Steps

• Continue to develop and commercialize the Breast Acoustic CT Scanner.
• Expand distribution channels and partnerships globally.
• Seek further regulatory approvals and clearances.
• Manage liquidity and secure additional financing as needed.
• Monitor and mitigate risks associated with geopolitical instability in the Middle East.

Key Dates

Recommendation

QT Imaging Holdings shows promising revenue growth and a significant improvement in net loss compared to the prior year. The Nasdaq uplisting and extended debt maturity are positive developments. However, the company remains unprofitable, has a substantial accumulated deficit, and faces ongoing liquidity challenges. The geopolitical risks in the Middle East also present a significant concern. Given these factors, a 'hold' recommendation is appropriate, awaiting further evidence of sustainable profitability and a clearer path to financial stability.

Keywords

QT Imaging Holdings, 10-Q, Medical Device, Breast Acoustic CT Scanner, Revenue Growth, Net Loss, Liquidity, Nasdaq, Distribution Agreements, Lynrock Lake Term Loan